Headlines Covid-19 Specialties Trending Feeds Videos

Wiley Online Library - Click on the article title to read...

Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm

posted 1 month


Mashup Score: 4

ScienceDirect - Journals & BooksRegisterSign inSign inRegisterJournals & BooksHelpAccess through your institutionto view subscribed content from homeAdvancedOutlineKeywordsKey pointsIntroductionLiterature reviewMechanism of actionPreclinical developmentClinical...

American Society of Hematology Publications - Key Points. According to next-generation deep sequencing, TN patients with ET may have “low-level” driver mutations affecting JAK2 or MPL.Gene expression...

Clinical Lymphoma, Myeloma and Leukemia - Micro-AbstractWe retrospectively analyzed the outcomes of 1412 patients with myelofibrosis stratified by bone marrow blasts and exposure to ruxolitinib (RUX). Patients with 5% to...

Virtual Meetings Open Up Online Communication for MPNs

posted 5 days


Mashup Score: 2

Targeted Oncology - In an interview with Targeted Oncology, Naveen Pemmaraju, MD, discussed recent advances for the treatment of patients with MPNs and shared his thoughts on...

Triplet therapy with venetoclax, FLT3 inhibitor and decitabine for FLT3-mutated acute myeloid leukemia

posted 2 weeks


Mashup Score: 1

Blood Cancer Journal - FLT3 mutations occur in 20–35% patients with newly diagnosed (ND) acute myeloid leukemia (AML) and confer a higher risk of relapse and inferior overall...

Houston, Seattle Feels Your Loss

posted 1 month


Mashup Score: 1

New York Times - With whipsawing trades and other player movement routine in the N.B.A. these days, it’s hard to be loyal to teams and...

Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms

posted 2 weeks


Mashup Score: 1

Taylor & Francis - (2020). Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms. Leukemia & Lymphoma. Ahead of...

Wiley Online Library - The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images...

Phase 2 study of lenalidomide maintenance for patients with high‐risk acute myeloid leukemia in remission

posted 4 weeks


Mashup Score: 1

American Cancer Society Journals - Lenalidomide maintenance in patients with high‐risk acute myeloid leukemia results in a 2‐year overall survival rate of 63%. The beneficial effect is most profound...